Buscar resultados de ensayos clínicos
Acute Leukemia of Ambiguous Lineage - 35 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: S1312, Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Leukemia Condición:
|
Recruiting |
Nombre del estudio: Blinatumomab and Nivolumab With or Without Ipilimumab in Treating Patients With Poor-Risk Relapsed or Refractory CD19+ Precursor B-Lymphoblastic Leukemia Condición:
|
Completed |
Nombre del estudio: Selinexor With Fludarabine and Cytarabine for Treatment of Refractory or Relapsed Leukemia or Myelodysplastic Syndrome Condición:
|
Recruiting |
Nombre del estudio: Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD Condición:
|
Active, not recruiting |
Nombre del estudio: Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts in Preventing GVHD in Children Condición:
|
Recruiting |
Nombre del estudio: Decitabine, Filgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome Condición:
|
Active, not recruiting |
Nombre del estudio: POETIC Plerixafor as a Chemosensitizing Agent for Relapsed Acute Leukemia and MDS in Pediatric Patients Condición:
|
Recruiting |
Nombre del estudio: Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes Condición:
Intervenciones: |
Recruiting |
Nombre del estudio: High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia Condición:
|
Active, not recruiting |
Nombre del estudio: Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation Condición:
Fecha: 2011-06-04 Intervenciones: Drug: levofloxacin Given PO or IV Other Names: |